The airways of cystic fibrosis (CF) patients are colonized by a restricted number of bacterial species, the most common being Haemophilus influenzae, Staphylococcus aureus and Pseudomonas aeruginosa. Bacterial persistence and neutrophilsdominated inflammation is supposed to contribute to loss of lung function, which ultimately can be solely resolved by lung transplantation. This is defined the end stage of CF disease and appears to be dominated by P. aeruginosa infection. Thus, with the aim to characterize P. aeruginosa end-stage isolates, we have analyzed some phenotypic traits of two strains isolated from CF explanted lungs, only one of which exhibited a mucoid phenotype (Pa-M). For comparison, reference laboratory and clinical strains were used. First, analysis of genetic diversity by RAPD suggested that the two isolates were unrelated. Next, different virulence factors such as motility, biofilm formation and production of effectors of the type III secretion system, were analyzed. The results obtained showed that, PaM and Pa-nonM dampened motility, either flagella-or pili-dependent, loss of ExoU secretion and displayed a reduced capacity to form biofilm on abiotic surfaces. Moreover, mutation frequency analysis allows to categorize Pa-nonM, but not PaM, as a mutator isolate. Additionally, in vitro infection assays of either murine or human macrophages demonstrated that, although both isolates were killed by macrophages, PaM survived better than Pa-nonM. Collectively, our results suggest that the winner strategy for bacteria to persist is to dampen their virulence factors.
The airways of cystic fibrosis (CF) patients are colonized by a restricted number of bacterial species, the most common being Haemophilus influenzae, Staphylococcus aureus and Pseudomonas aeruginosa. Bacterial persistence and neutrophilsdominated inflammation is supposed to contribute to loss of lung function, which ultimately can be solely resolved by lung transplantation. This is defined the end stage of CF disease and appears to be dominated by P. aeruginosa infection. Thus, with the aim to characterize P. aeruginosa end-stage isolates, we have analyzed some phenotypic traits of two strains isolated from CF explanted lungs, only one of which exhibited a mucoid phenotype (Pa-M). For comparison, reference laboratory and clinical strains were used. First, analysis of genetic diversity by RAPD suggested that the two isolates were unrelated. Next, different virulence factors such as motility, biofilm formation and production of effectors of the type III secretion system, were analyzed. The results obtained showed that, PaM and Pa-nonM dampened motility, either flagella-or pili-dependent, loss of ExoU secretion and displayed a reduced capacity to form biofilm on abiotic surfaces. Moreover, mutation frequency analysis allows to categorize Pa-nonM, but not PaM, as a mutator isolate. Additionally, in vitro infection assays of either murine or human macrophages demonstrated that, although both isolates were killed by macrophages, PaM survived better than Pa-nonM. Collectively, our results suggest that the winner strategy for bacteria to persist is to dampen their virulence factors. Objectives: Recent studies demonstrated the impact of methicillin-resistant Staphylococcus aureus (MRSA) on survival of CF patients. Community-acquired MRSA (CA-MRSA) have started to replace hospital-acquired MRSA (HA-MRSA) strains in hospital settings, and these definitions started to blur. An additional threat for CF patients is represented by PVL-positive MRSA strains, able to cause invasive lung infections including lung abscesses. The main goal of this study was to assess the presence of PVL-positive MRSA strains, and to investigate their genetic background in order to obtain a more delineated epidemiological picture. Methods: SCCmec typing was performed according to published protocols (Oliveira and de Lancastre, 2002), as well as Multi Locus Sequence Typing (MLST) analysis (Enright et al, 2000) . PVL genes presence was tested using a previously published method (Lina et al, 1999) . Results: 38 MRSA strains, one/patient, median age 20.5 (range 2−48) were screened for the presence of PVL genes. Only 1 strain infecting a 9 years-old patient tested positive. 23 out of 38 strains (60%) belonged to HA-MRSA group, the remaining 15 (40%) to CA-MRSA. Several epidemic lineages, such as Southern Germany, Berlin and Archaic clone were found, while the only PVL-positive strain belonged to ST152. Conclusion: PVL-positive strains were described in CF population in US as well as in Brazil, but their diffusion remains still unclear. Further studies should be promoted to assess the epidemiology of PVL-positive MRSA strains infecting CF patients in order to avoid their spread. We have adopted a strict segregation policy based on effective microbiological surveillance for many years now at our large adult CF unit (285 patients), and we wished to assess the incidence of NTM in our patient population. Method: As part of their routine annual screen and at other appropriate times, we aim to send sputum samples from our CF patients for NTM smear and culture: those with a positive result are then sent to the national reference laboratory for species identification. We interrogated our database to assess the incidence of NTM in our clinic. 
Conclusions:
The study has shown that we have a low incidence of NTM in our large adult clinic, in particular with M. abscessus (2%) which has previously been associated with poor cross infection control. We continue to conduct effective microbiological surveillance to prevent cross-infection in our clinic. . A great genetic diversity was observed by PFGE and MLST techniques, even inside each CF-Unit. Non-previously described alleles were found, and new STs were assigned. The ST175 and ST111 clones, frequently implicated in nosocomial bacteremias in Spain, were scarcely represented. Conclusion: In Spain, lung colonization/infection by P. aeruginosa was observed in 27.7% of the adults and 15.3% of children. These isolates correspond to unrelated genetic lineages and were multi-resistant to antibiotics.
